The extra MHRA funding will help accelerate patient access to new treatments, says the government. Pic: getty/221A

MHRA gets £10m boost from UK government

By Rachel Arthur

The UK Medicines and Healthcare products Regulatory Agency (MHRA) will receive £10m ($12m) in extra government funding over the next two years: targeted at helping the agency adapt post-Brexit and accelerating routes for bringing new medicines onto the...

© GettyImages/Tanaonte

Guest Article

What does Brexit mean for biopharma companies?

By Mike Pears and Joel Beevers, Patent Attorneys at Potter Clarkson

January 1, 2021 marked the UK’s official separation from the EU and with that has come a raft of changes to how the nation will now do business with the rest of the world.